These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16051811)

  • 1. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.
    Ulane CM; Kentsis A; Cruz CD; Parisien JP; Schneider KL; Horvath CM
    J Virol; 2005 Aug; 79(16):10180-9. PubMed ID: 16051811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components.
    Ulane CM; Horvath CM
    Virology; 2002 Dec; 304(2):160-6. PubMed ID: 12504558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1.
    Precious B; Childs K; Fitzpatrick-Swallow V; Goodbourn S; Randall RE
    J Virol; 2005 Nov; 79(21):13434-41. PubMed ID: 16227264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5.
    Andrejeva J; Poole E; Young DF; Goodbourn S; Randall RE
    J Virol; 2002 Nov; 76(22):11379-86. PubMed ID: 12388698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons.
    Andrejeva J; Young DF; Goodbourn S; Randall RE
    J Virol; 2002 Mar; 76(5):2159-67. PubMed ID: 11836393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2.
    Precious B; Young DF; Andrejeva L; Goodbourn S; Randall RE
    J Gen Virol; 2005 Jan; 86(Pt 1):151-158. PubMed ID: 15604442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction.
    Parisien JP; Lau JF; Rodriguez JJ; Ulane CM; Horvath CM
    J Virol; 2002 May; 76(9):4190-8. PubMed ID: 11932384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling.
    Ulane CM; Rodriguez JJ; Parisien JP; Horvath CM
    J Virol; 2003 Jun; 77(11):6385-93. PubMed ID: 12743296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.
    Parisien JP; Lau JF; Horvath CM
    J Virol; 2002 Jul; 76(13):6435-41. PubMed ID: 12050355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.
    Rosas-Murrieta NH; Herrera-Camacho I; Palma-Ocampo H; Santos-López G; Reyes-Leyva J
    Virol J; 2010 Oct; 7():263. PubMed ID: 20937132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.
    Nishio M; Tsurudome M; Ito M; Garcin D; Kolakofsky D; Ito Y
    J Virol; 2005 Jul; 79(13):8591-601. PubMed ID: 15956600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death.
    Wansley EK; Parks GD
    J Virol; 2002 Oct; 76(20):10109-21. PubMed ID: 12239285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.
    Young DF; Didcock L; Goodbourn S; Randall RE
    Virology; 2000 Apr; 269(2):383-90. PubMed ID: 10753717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting.
    Puri M; Lemon K; Duprex WP; Rima BK; Horvath CM
    J Virol; 2009 Jul; 83(13):6347-56. PubMed ID: 19386700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic turnover of STAT1 allows PIV5 to dismantle the interferon-induced anti-viral state of cells.
    Precious BL; Carlos TS; Goodbourn S; Randall RE
    Virology; 2007 Nov; 368(1):114-21. PubMed ID: 17640695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities.
    Leupin O; Bontron S; Strubin M
    J Virol; 2003 Jun; 77(11):6274-83. PubMed ID: 12743284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V protein.
    Yokosawa N; Yokota S; Kubota T; Fujii N
    J Virol; 2002 Dec; 76(24):12683-90. PubMed ID: 12438594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.
    Rodriguez JJ; Parisien JP; Horvath CM
    J Virol; 2002 Nov; 76(22):11476-83. PubMed ID: 12388709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion.
    Rodriguez JJ; Cruz CD; Horvath CM
    J Virol; 2004 May; 78(10):5358-67. PubMed ID: 15113915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into Viral Hijacking of CRL4 Ubiquitin Ligase through Structural Analysis of the pUL145-DDB1 Complex.
    Wick ET; Treadway CJ; Li Z; Nicely NI; Ren Z; Baldwin AS; Xiong Y; Harrison JS; Brown NG
    J Virol; 2022 Sep; 96(17):e0082622. PubMed ID: 35938868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.